426 related articles for article (PubMed ID: 27023445)
1. Clinical Utility of Biomarkers in Localized Prostate Cancer.
Leapman MS; Nguyen HG; Cooperberg MR
Curr Oncol Rep; 2016 May; 18(5):30. PubMed ID: 27023445
[TBL] [Abstract][Full Text] [Related]
2. [PSA 2010--the beginning of a new era in early detection of prostate cancer].
Börgermann C; Sieverding M; Fornara P; Graefen M; Hammerer P; Semjonow A; Schröder F; Rübben H
Urologe A; 2006 Sep; 45 Suppl 4():127-33. PubMed ID: 16941115
[No Abstract] [Full Text] [Related]
3. What is the best way not to treat prostate cancer?
Leapman MS; Carroll PR
Urol Oncol; 2017 Feb; 35(2):42-50. PubMed ID: 27746147
[TBL] [Abstract][Full Text] [Related]
4. Prostate-specific antigen and other serum and urine markers in prostate cancer.
Stephan C; Ralla B; Jung K
Biochim Biophys Acta; 2014 Aug; 1846(1):99-112. PubMed ID: 24727384
[TBL] [Abstract][Full Text] [Related]
5. [Significance of the PSA-concentration for the detection of prostate cancer].
Stachon A
Pathologe; 2005 Nov; 26(6):469-72. PubMed ID: 16195861
[TBL] [Abstract][Full Text] [Related]
6. [New serum markers in prostate carcinoma and their application to artificial neural networks].
Stephan C; Jung K; Cammann H; Kramer J; Kristiansen G; Loening SA; Lein M
Urologe A; 2007 Sep; 46(9):1084-6. PubMed ID: 17641867
[No Abstract] [Full Text] [Related]
7. [Non- PSA serum markers for the diagnosis of PCa].
Mengual L; Musquera M; Ciudin A; Ribal MJ
Arch Esp Urol; 2015 Apr; 68(3):229-39. PubMed ID: 25948796
[TBL] [Abstract][Full Text] [Related]
8. Risk stratification of prostate cancer 2016.
Reiter RE
Scand J Clin Lab Invest Suppl; 2016; 245():S54-9. PubMed ID: 27533326
[TBL] [Abstract][Full Text] [Related]
9. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy.
McKiernan J; Donovan MJ; O'Neill V; Bentink S; Noerholm M; Belzer S; Skog J; Kattan MW; Partin A; Andriole G; Brown G; Wei JT; Thompson IM; Carroll P
JAMA Oncol; 2016 Jul; 2(7):882-9. PubMed ID: 27032035
[TBL] [Abstract][Full Text] [Related]
10. Urinary miR-183 and miR-205 do not surpass PCA3 in urine as predictive markers for prostate biopsy outcome despite their highly dysregulated expression in prostate cancer tissue.
Stephan C; Jung M; Rabenhorst S; Kilic E; Jung K
Clin Chem Lab Med; 2015 Jun; 53(7):1109-18. PubMed ID: 25720086
[TBL] [Abstract][Full Text] [Related]
11. [Emerging biomarkers for the diagnosis, staging and prognosis of prostate cancer].
Mazzola CR; Ghoneim T; Shariat SF
Prog Urol; 2011 Jan; 21(1):1-10. PubMed ID: 21193139
[TBL] [Abstract][Full Text] [Related]
12. [Clinical utility of available diagnostic tests in prostatic carcinoma. Results of 500 biopsies. I. PSA, PSA density, and predicted PSA].
Rodríguez Rodríguez R; Mayayo Dehesa T; Galbis Sanjuan F; Jiménez Cidre M; Burgos Revilla FJ; Allona Almagro A; Gomez dos Santos V
Arch Esp Urol; 1997 May; 50(4):333-8. PubMed ID: 9313041
[TBL] [Abstract][Full Text] [Related]
13. The role of genetic markers in the management of prostate cancer.
Choudhury AD; Eeles R; Freedland SJ; Isaacs WB; Pomerantz MM; Schalken JA; Tammela TL; Visakorpi T
Eur Urol; 2012 Oct; 62(4):577-87. PubMed ID: 22695242
[TBL] [Abstract][Full Text] [Related]
14. Circulating biomarkers for prostate cancer.
Steuber T; Helo P; Lilja H
World J Urol; 2007 Apr; 25(2):111-9. PubMed ID: 17345087
[TBL] [Abstract][Full Text] [Related]
15. New Genetic Markers for Prostate Cancer.
Leapman MS; Carroll PR
Urol Clin North Am; 2016 Feb; 43(1):7-15. PubMed ID: 26614025
[TBL] [Abstract][Full Text] [Related]
16. Re: The prostate specific antigen era in the United States is over for prostate cancer: what happened in the last 20 years?
Hoeltl W; Müller MM; Lunglmayr G
J Urol; 2005 Jun; 173(6):2205; author reply 2205-6. PubMed ID: 15879895
[No Abstract] [Full Text] [Related]
17. Prostatic specific antigen (PSA).
Alberti C
Minerva Urol Nefrol; 1993 Jun; 45(2):83-4. PubMed ID: 7694380
[No Abstract] [Full Text] [Related]
18. Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer.
Hagiwara K; Tobisawa Y; Kaya T; Kaneko T; Hatakeyama S; Mori K; Hashimoto Y; Koie T; Suda Y; Ohyama C; Yoneyama T
Int J Mol Sci; 2017 Jan; 18(2):. PubMed ID: 28134773
[No Abstract] [Full Text] [Related]
19. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers for early prostate cancer detection.
Margreiter M; Stangelberger A; Valimberti E; Herwig R; Djavan B
Minerva Urol Nefrol; 2008 Mar; 60(1):51-60. PubMed ID: 18427435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
